All blog posts
Total 41 results for
Showing 12 out of 41 results
03 março 2025
Latest CRTea podcast now available: Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
23 dezembro 2024
Le Patourel v BT - First competition class action to go to trial fails: key takeaways and implications for the regime
01 novembro 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
14 outubro 2024
Highlights from the GCR Live: Competition Litigation conference
07 outubro 2024
General Court largely rejects Qualcomm's challenge to Commission's predatory pricing decision
04 julho 2024
Insights from the latest "pay-for-delay" CJEU judgments: fines on Servier and generics drug manufacturers largely upheld (but not over yet)
21 dezembro 2023
Clarity: Over the Hills and (F)Far Away? The FIFA Football Agents Regulations and their interplay with competition law
06 dezembro 2023
Competition law and biosimilars: Time for a new approach or not yet?
15 agosto 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 junho 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
14 abril 2023
European Commission announces plans for new Article 102 TFEU Guidelines and amends 2008 Guidance on enforcement priorities
24 março 2023
Non-notifiable M&A deals can be reviewed under abuse of dominance rules: does heightened regulatory intervention in deal-making lie ahead?
Showing 12 out of 41 results
View more